329 related articles for article (PubMed ID: 25268603)
1. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.
Mancikova A; Krylov V; Hurba O; Sebesta I; Nakamura M; Ichida K; Stiburkova B
Clin Exp Nephrol; 2016 Aug; 20(4):578-584. PubMed ID: 26500098
[TBL] [Abstract][Full Text] [Related]
3. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
4. Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.
Zhou Z; Wang K; Zhou J; Wang C; Li X; Cui L; Han L; Liu Z; Ren W; Wang X; Zhang K; Li Z; Pan D; Li C; Shi Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00722. PubMed ID: 31131560
[TBL] [Abstract][Full Text] [Related]
5. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic Variants of
Perdomo-Ramirez A; Cordoba-Lanus E; Trujillo-Frias CJ; Gonzalez-Navasa C; Ramos-Trujillo E; Luis-Yanes MI; Garcia-Nieto V; Claverie-Martin F;
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176161
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Influence of Genetic Variants of
Pavelcova K; Bohata J; Pavlikova M; Bubenikova E; Pavelka K; Stiburkova B
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32759716
[TBL] [Abstract][Full Text] [Related]
8. Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.
Tu HP; Chung CM; Min-Shan Ko A; Lee SS; Lai HM; Lee CH; Huang CM; Liu CS; Ko YC
J Hum Genet; 2016 Sep; 61(9):803-10. PubMed ID: 27225847
[TBL] [Abstract][Full Text] [Related]
9. Genetic Association Between
Zheng Q; Keliang W; Hongtao Q; Xiaosheng L
Genet Test Mol Biomarkers; 2022 Feb; 26(2):81-95. PubMed ID: 35225677
[No Abstract] [Full Text] [Related]
10. [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].
Ichida K
Yakugaku Zasshi; 2024; 144(6):659-674. PubMed ID: 38825475
[TBL] [Abstract][Full Text] [Related]
11. The genetics of hyperuricaemia and gout.
Reginato AM; Mount DB; Yang I; Choi HK
Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
Liu J; Yang W; Li Y; Wei Z; Dan X
BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
[TBL] [Abstract][Full Text] [Related]
13. Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.
Tu HP; Min-Shan Ko A; Lee SS; Lee CP; Kuo TM; Huang CM; Ko YC
J Hum Genet; 2018 Jan; 63(1):63-70. PubMed ID: 29215084
[TBL] [Abstract][Full Text] [Related]
14. Examining the Association of Rare Allelic Variants in Urate Transporters
Vávra J; Pavelcová K; Mašínová J; Hasíková L; Bubeníková E; Urbanová A; Mančíková A; Stibůrková B
Dis Markers; 2024; 2024():5930566. PubMed ID: 38222853
[TBL] [Abstract][Full Text] [Related]
15. Hereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease.
Stiburkova B; Stekrova J; Nakamura M; Ichida K
Am J Med Sci; 2015 Oct; 350(4):268-71. PubMed ID: 26418379
[TBL] [Abstract][Full Text] [Related]
16. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
17. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
[TBL] [Abstract][Full Text] [Related]
18. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.
Torres RJ; de Miguel E; Bailén R; Banegas JR; Puig JG
J Rheumatol; 2014 Sep; 41(9):1863-70. PubMed ID: 25128519
[TBL] [Abstract][Full Text] [Related]
19. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
Tin A; Woodward OM; Kao WH; Liu CT; Lu X; Nalls MA; Shriner D; Semmo M; Akylbekova EL; Wyatt SB; Hwang SJ; Yang Q; Zonderman AB; Adeyemo AA; Palmer C; Meng Y; Reilly M; Shlipak MG; Siscovick D; Evans MK; Rotimi CN; Flessner MF; Köttgen M; Cupples LA; Fox CS; Köttgen A;
Hum Mol Genet; 2011 Oct; 20(20):4056-68. PubMed ID: 21768215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
